While the topic may still lack clear scientific answers, patients can protect themselves by making decisions based on caution, not convenience
Seven additional Phase 3 readouts are expected throughout 2026, including studies evaluating maintenance dosing at 4 mg (in addition to the 9 mg and 12 mg doses already tested)
Dosage, Administration, and What to Expect Both medicines are given as once-weekly subcutaneous injections with gradual dose titration
You may be a good candidate if you: Are not currently using another GLP-1 medication Struggle with losing weight despite diet and exercise Have no history of certain thyroid cancers, major kidney disease, or pancreatitis Do not have severe allergies to similar medications Are committed to making healthy lifestyle changes alongside treatment Have realistic expectations about your results Can reliably administer injections at home, or prefer in-office administration Personalized Evaluation During your consultation, your provider will review your medical history, medications, and health goals
Louis MO, USA) for 10 minutes, 1 h, or 24 h
Use it daily for best results
